Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 3
2012 14
2013 2
2014 3
2015 1
2016 2
2017 5
2018 7
2019 6
2020 3
2022 1
2023 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 31643440

35 results

Results by year

Filters applied: . Clear all
Page 1
Pazopanib.
[No authors listed] [No authors listed] 2020 May 10. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 May 10. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643440 Free Books & Documents. Review.
Pazopanib in advanced soft tissue sarcomas.
Lee ATJ, Jones RL, Huang PH. Lee ATJ, et al. Signal Transduct Target Ther. 2019 May 17;4:16. doi: 10.1038/s41392-019-0049-6. eCollection 2019. Signal Transduct Target Ther. 2019. PMID: 31123606 Free PMC article. Review.
Axitinib.
[No authors listed] [No authors listed] 2017 Aug 1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Aug 1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643469 Free Books & Documents. Review.
Pazopanib in the management of advanced soft tissue sarcomas.
Cranmer LD, Loggers ET, Pollack SM. Cranmer LD, et al. Ther Clin Risk Manag. 2016 Jun 9;12:941-55. doi: 10.2147/TCRM.S84792. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 27354810 Free PMC article. Review.
Sorafenib.
[No authors listed] [No authors listed] 2018 Jun 22. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2018 Jun 22. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644249 Free Books & Documents. Review.
Vemurafenib.
[No authors listed] [No authors listed] 2018 Jun 28. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2018 Jun 28. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643967 Free Books & Documents. Review.
Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.
Deguchi S, Mitsuya K, Nakasu Y, Hayashi N, Katagiri H, Murata H, Wasa J, Takahashi M, Endo M. Deguchi S, et al. Invest New Drugs. 2018 Apr;36(2):346-349. doi: 10.1007/s10637-017-0521-5. Epub 2017 Oct 25. Invest New Drugs. 2018. PMID: 29067537 Free PMC article. Review.
35 results